index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications with fulltext

Open Access

46 %

Mots clés

Glucocorticoids Inflammatory cytokines Ferrites Acides nucléiques endogènes Myasthénie grave Endogenous nucleic acids Interferon-β M3243AG Neuromuscular junction Thymus Gd T cells Fragile X syndromes Interleukin 23 Ectopic germinal centers Autoimmune diseases Autoimmune disease Anticorps monoclonal CXCL13-CXCR5 Adaptive immunity Experimental autoimmune myasthenia gravis EAMG Th17 cells Thymoma CCL21 Max Heart failure Experimental autoimmune myasthenia gravis COX2 Disease susceptibility Mass cytometry CyTOF Transcriptome MG patients Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Interferon type I Complete Freund's adjuvant Thymic epithelial cells Cardiomyopathy Long-term follow-up FMR1 BAFF Human myoblasts Chemokine Acetylcholine receptor antibodies Genetic associations Germinal centers Germinal center Myasthenia Gravis MG Immunology and Microbiology Section Experimental models Genetics Immune regulation Immunity Etiology Experimental mouse models Myoblasts Auto-immunité DICER Interféron de type I COVID-19 Centres germinatifs ectopiques MYB Conduction disease Immunotherapy Immune response Macrophages MiR-125 Chronic inflammation Innate immunity Cellules th17 Gender Interferonopathy Chronicity Antimir-150 Interleukine-23 Interferon IFN Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Interferon type-I Quality of life PBMC Early-onset myasthenia gravis B cells Clinical cell transplantation LMNA Maladie auto-immune Myasthenia gravis AChR antibodies Chemokines Acetylcholine receptor Il-23 CD31 Autoimmunity CTCF Exercise Inflammation Animal models Interferon de type I Lamin A/C nuclei Interferon Acetylcholine receptors Cytokines MiR-7